REthinking Clinical Trials (REaCT)
Studies
REaCT studies typically focus on comparing commonly-used treatments, rather than testing new treatments.
They are designed so that a wide range of people with cancer can easily participate without the need for extra tests, hospital visits or lengthy consent forms. Data are typically gathered in real-time from electronic medical records and through quality-of-life surveys. By simplifying the process, REaCT trials can involve more patients and produce results that more accurately reflect the patient population. REaCT trials also have economic evaluation embedded to ensure evaluation of value to both patients and the health-care system.
On this page:
How do I participate?
Patients who are interested in learning more about a REaCT trial should speak with their primary care physician.
All REaCT studies are registered on a public registry (www.ClinicalTrials.gov) which lists all study details including criteria for participation, treatments being compared, current status of the study, and contact information for the principal investigator.